IRCCS Policlinico San Donato
Milan, Italy
NCT Number: NCT03685097
This study will investigate the correlation and agreement of Quantra-derived parameters with parameters reported by the ROTEM delta and standard laboratory tests in cardiac surgery patients. In addition the association of Quantra-derived parameters with select platelet function tests will be investigated.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Milan, Italy
The Quantra System is a fully integrated and automated in vitro diagnostic device which uses SEER Sonorheometry, an ultrasound-based technology, to characterize the viscoelastic properties of a whole blood sample during coagulation. The Quantra QPlus Cartridge (previously called the Surgical Cartridge), was developed to monitor hemostasis during major surgical procedures in adult patients. The cartridge provides six parameters that depict the functional status of a patient's coagulation system.
This single site, prospective observational study will investigate the correlation and agreement of Quantra-derived parameters with parameters reported by the ROTEM delta and standard laboratory tests (PT, aPTT, fibrinogen, platelet count) in cardiac surgery patients. As an additional exploratory study, the association of Quantra-derived parameters with select platelet function tests will be investigated.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Point-of-care viscoelastic testing
Time frame: Baseline (before surgery)
Coagulation function assessed by Quantra QPlus Cartridge and ROTEM delta
Time frame: After cardiac bypass (10 minutes after administration of protamine)
Coagulation function assessed by Quantra QPlus Cartridge and ROTEM delta
Time frame: Baseline (before surgery)
Coagulation function assessed by Quantra QPlus Cartridge and standard coagulation tests
Time frame: After cardiac bypass (10 minutes after administration of protamine)
Coagulation function assessed by Quantra QPlus Cartridge and standard coagulation tests
Time frame: Baseline (before surgery)
Platelet function assessed by Quantra QPlus Cartridge and MEA
Time frame: After cardiac bypass (10 minutes after administration of protamine)
Platelet function assessed by Quantra QPlus Cartridge and MEA
HemoSonics LLC
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06517563
Cardiovascular Diseases, Coagulation Disorder
Groningen, Netherlands
View Trial DetailsNCT07470385
Cardiovascular Diseases, Coagulation Disorder
Changsha, Hunan, China
View Trial DetailsNCT03826043
Cardiovascular Diseases, Coagulation Disorder
Nice, France
View Trial DetailsNCT05484830
Acute Aortic Dissection, Cardiovascular Diseases
Aarhus, Denmark
View Trial Details